The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

Functional interplay of sex hormones in estrogen receptor–positive breast cancer unveils the therapeutic potential of androgen receptor agonists and support AR agonism as the optimal AR-directed treatment strategy, revealing a rational therapeutic opportunity.